search
Back to results

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. (PIONEER)

Primary Purpose

NSCLC

Status
Terminated
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
paclitaxel
paclitaxel poliglumex
Sponsored by
CTI BioPharma
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for NSCLC focused on measuring Non-small cell lung cancer, NSCLC, PS 2, female, chemotherapy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Female. Histologically- or cytologically-confirmed diagnosis of NSCLC. ECOG performance score of 2. Patients who meet one of the following criteria: Stage IIIB who are not candidates for combined modality therapy (primary radiation therapy or surgery), or Stage IV. Age greater than or equal to 18 years. Adequate bone marrow function Adequate renal function Adequate hepatic function Patients with known brain metastases must have received standard antitumor treatment for their CNS metastases as defined by the site's institutional standards. Patients who have had major surgery must be fully recovered from the surgery. Ability to comply with the visit schedule and assessments required by the protocol. For patients of reproductive potential, commitment to use adequate contraception. Signed approved informed consent, with understanding of study procedures. Agreement to begin study therapy within 8 calendar days after randomization. Exclusion Criteria: Any intolerance to poly-L-glutamic acid, Poloxamer 188, dibasic sodium phosphate, monobasic sodium phosphate (the excipients of CT-2103). Evidence of small cell carcinoma, carcinoid, or mixed small cell/non-small cell histology. Any prior systemic chemotherapy for the treatment of lung cancer. This includes systemic radiosensitizers used to treat brain metastases and any biologic agent. Concurrent primary malignancies except for carcinoma in situ or non-melanoma skin cancer. Grade 2 or greater neuropathy. Evidence of significant unstable neurological symptoms within the 4 weeks before study randomization. (If unstable neurologic symptoms resulted from brain metastases, patient must meet inclusion criteria number 9). Clinically significant active infection for which active therapy is underway. Investigational therapy within 4 weeks before randomization, unless local requirements are more stringent. Unstable medical conditions including unstable angina or myocardial infarction within the past 6 months before randomization. Patients with evidence of cardiac conduction abnormalities are eligible if their cardiac status is stable. Pregnant women or nursing mothers. Any circumstance at the time of study entry that would preclude completion of the study or the required follow-up.

Sites / Locations

  • Desert Oasis Cancer Center
  • Arizona Hematology Oncology
  • Genesis Cancer Center
  • Heritage Physician Group, Oncology
  • Pacific Cancer Medical Center, Inc
  • Comprehensive Blood and Cancer Center
  • Tower Cancer Research Foundation
  • Providence St. Joseph Medical Center
  • Hematology/Oncology Group of Fresno, Inc
  • Comprehensive Cancer Center-Research Office
  • Loma Linda University Cancer Institute
  • Pacific Shores Medical Group
  • Medical Oncology Care Associates
  • The Cancer Research and Prevention Center
  • Bethesda Research Center
  • Broward Oncology Associates
  • Florida Wellcare
  • Cancer & Blood Disease Center
  • Oncology-Hematology Associates of West Broward
  • Hematology Oncology Speaclist
  • Joliet Oncology Hematology Associates, Ltd.
  • Loyola University Health Systems
  • Mid-Illinois HEM & ONC Assoc.
  • Northern Indiana Cancer Research Consortium
  • Associated Physicians & Surgeons Clinic
  • Kentucky Cancer Clinic
  • West Kentucky Hematology & Oncology Group, PSC
  • Cabrini Center for Cancer Care
  • West Michigan Cancer Center
  • Oncology Care Associates, PLLC
  • Hubert H. Humphrey Cancer Center
  • St. Louis Cancer Care Center
  • Columbia Comprehensive Cancer Care Clinics
  • Bond Clinic
  • Saint Louis University
  • Washington University Siteman Cancer Center Pharmacy
  • Montana Cancer Specialists
  • Sierra Nevada Oncology Care
  • Essex Oncology of North Jersey, PA
  • Atlanta HEM ONC
  • Oncology and Hematology Specialist, PA
  • San Juan Oncology Association
  • Our Lady of Mercy Medical Center
  • Suny Downstate Medical Center
  • Cancer Treatment Services
  • Interlakes Foundation, Inc.
  • Guthrie Clinic
  • New York Medical Collegw
  • Alamance Cancer Center
  • UNC Chapel Hill Oncology Protocol Office
  • Leo Jenkins Cancer Center
  • Northwestern Carolina Oncology & Hematology
  • St. Alexius Medical Center
  • University of Cleveland
  • Metro Health Medical Center
  • The Cleveland Clinic Foundation, Taussig Cancer Center
  • Dayton Clinical Oncology Program
  • Signal Point Hematology/Oncology, Inc.
  • Charleston Hematology Oncology
  • The Family Cancer Center
  • Mary Crowley Medical Research Center
  • JPS Center for Cancer Care
  • Columbia Basin HEM/ONC
  • Sanatorio Parque
  • CETEN
  • Hospital Privado de Comunidad
  • Hospital General de Agudos "Dr Teodoro Alvarez"
  • Instituto Alexander Fleming
  • Instituto Oncologico de Cordoba - IONC
  • LUCEN
  • ISIS Clinica Especializada
  • District Oncology Dispensary
  • District Oncolodispensary with Impatient sector
  • Military Medical Academy
  • Regional Oncology Dispensary with Inpatient Secot-Sofia District
  • Regional Oncology Dispensary with Inpatient Sector
  • University Mulitprofile Hospital for Active Treatment "Sveta Marina"
  • University Multiprofile Hospital for Active Treatment "Sveta Marina"
  • Regional Oncology Dispensary with Inpatient sector
  • Jewish General Hospital
  • Erzsebet Juhasz
  • University of Debrecen, Pulmonology Clinic
  • Hospital for Thoracic Diseases of Csongrad Country
  • Pulmonology Institute of Veszprem County
  • Hospital for Pulmonological Diseases of the Bekes County
  • Hospital of the Chest Desease of the Hungarian Reformed Church
  • Karolina Hospital
  • Barany County Hospital
  • Erzsebet Hospital
  • Sanatorium for Pulmonological Diseases
  • Centenario Hospital Miguel Hidalgo
  • CIMA Chihuahua
  • Hospital General
  • Instituto Estatal de Cancerologia "Dr. Arturo Beltran Ortega"
  • Hospital Dr. Angel Leano
  • Hospital Star Medica Morelina
  • Monterrey International Research Center
  • Centro Estatal de Canceologia
  • Centro Anticanceroso de la Cruz Roja Mexicana de Merida
  • Centro Estatal de Cancerologia
  • Hospital Central "Dr. Ignacio Morones Prieto"
  • Hospital General Regional
  • Kujawsko-Pomorskie Centrum Pulmunologii
  • Krakowski Szpital Specjelistyczny
  • Centrum Onkologii Ziemii Lubelskiej
  • Zaklad Opieki Zdrowotnej Ministerstaw Spraw Wewnetrznych i Administraeji
  • Mazowleckie Centrum leczenia Chorob Pluc i Gruzlicy
  • Wielkopolskie Centrum Chorob Pluc i Gruzlicy, Samodzielmy Publiczny ZOZ
  • SPSK nr l im. Przemienienia AM w Poznaniu
  • MSc Grezegorz Jedrejezak
  • Dolnoslaskie Centrum Chorob Pluc ul. Grabiszynska 105
  • Institutul Oncologie - Clinic de Oncologie Medicala
  • Prof. Dr. Al. Trestioreanu Institute of Oncology
  • "Prof. Dr. I. Chiricuta" Institute of Oncology
  • Emergency Clinical County Hospital
  • Oradea Clinical County Hospital
  • Clinical County Hospital
  • Timisoara Emergency Clinical Municipal Hospital
  • Chelyabinsk Regional Oncology Center
  • Krasnodar City Oncology Center
  • Moscow Municpal Oncology Hospital #62
  • Moscow Oncology Clinical Dispensary #1
  • SI Russian Oncological Scientific Center after N.N. Blokhim RAMS
  • SI Russian Oncological Scientific Center after N.N. Blokhin RAMS
  • Centeral ClinicalHospital of the President o the Russian Federation
  • Omsk Regional Oncology Center
  • Orenburg Regional Oncology Clinical Center
  • St. Petersburg City Clinical Oncology Center
  • Lenigrad Regional Oncology Center
  • Leningrad Regional Clinical Hospital
  • St. Petersbrug State Medical Pavlov University
  • Donetsk Regional Antineoplastic Center
  • Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk Medical University
  • Instiute of Oncology under AMS of Ukraine
  • Volyn Regional Oncology Dispensary
  • Uzhgorod National University, Regional Clinical Oncology Dispensary
  • Vinnitsa State Medical University
  • Zaporizhzhya Regional Oncology Dispensary
  • The Royal Bournemouth Hospital
  • Oncology Pharmacy
  • Wythenshaw Hospital, Pharmacy Department
  • Southhampton General Hospital

Outcomes

Primary Outcome Measures

The primary objective of this study is to compare the overall survival of female patients randomized to CT-2103 to that of female patients randomized to paclitaxel.

Secondary Outcome Measures

Secondary objectives are to compare the progression-free survival, response rate, disease control, clinical benefit, quality of life, and the safety and tolerability of the treatment arms.

Full Information

First Posted
December 22, 2005
Last Updated
November 23, 2020
Sponsor
CTI BioPharma
search

1. Study Identification

Unique Protocol Identification Number
NCT00269828
Brief Title
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
Acronym
PIONEER
Official Title
Paclitaxel Poliglumex (CT-2103) vs. Paclitaxel for the Treatment of Women With Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer (NSCLC) Who Are Performance Status 2.
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Terminated
Study Start Date
December 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2006 (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
CTI BioPharma

4. Oversight

5. Study Description

Brief Summary
This is a randomized, open-label, multinational, phase III study in women with histologically- or cytologically-confirmed advanced NSCLC who are chemotherapy naïve and have PS 2. Study drug will be administered on day 1 of each 21 day cycle
Detailed Description
See Summary

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
NSCLC
Keywords
Non-small cell lung cancer, NSCLC, PS 2, female, chemotherapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
600 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
paclitaxel
Intervention Type
Drug
Intervention Name(s)
paclitaxel poliglumex
Primary Outcome Measure Information:
Title
The primary objective of this study is to compare the overall survival of female patients randomized to CT-2103 to that of female patients randomized to paclitaxel.
Secondary Outcome Measure Information:
Title
Secondary objectives are to compare the progression-free survival, response rate, disease control, clinical benefit, quality of life, and the safety and tolerability of the treatment arms.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Female. Histologically- or cytologically-confirmed diagnosis of NSCLC. ECOG performance score of 2. Patients who meet one of the following criteria: Stage IIIB who are not candidates for combined modality therapy (primary radiation therapy or surgery), or Stage IV. Age greater than or equal to 18 years. Adequate bone marrow function Adequate renal function Adequate hepatic function Patients with known brain metastases must have received standard antitumor treatment for their CNS metastases as defined by the site's institutional standards. Patients who have had major surgery must be fully recovered from the surgery. Ability to comply with the visit schedule and assessments required by the protocol. For patients of reproductive potential, commitment to use adequate contraception. Signed approved informed consent, with understanding of study procedures. Agreement to begin study therapy within 8 calendar days after randomization. Exclusion Criteria: Any intolerance to poly-L-glutamic acid, Poloxamer 188, dibasic sodium phosphate, monobasic sodium phosphate (the excipients of CT-2103). Evidence of small cell carcinoma, carcinoid, or mixed small cell/non-small cell histology. Any prior systemic chemotherapy for the treatment of lung cancer. This includes systemic radiosensitizers used to treat brain metastases and any biologic agent. Concurrent primary malignancies except for carcinoma in situ or non-melanoma skin cancer. Grade 2 or greater neuropathy. Evidence of significant unstable neurological symptoms within the 4 weeks before study randomization. (If unstable neurologic symptoms resulted from brain metastases, patient must meet inclusion criteria number 9). Clinically significant active infection for which active therapy is underway. Investigational therapy within 4 weeks before randomization, unless local requirements are more stringent. Unstable medical conditions including unstable angina or myocardial infarction within the past 6 months before randomization. Patients with evidence of cardiac conduction abnormalities are eligible if their cardiac status is stable. Pregnant women or nursing mothers. Any circumstance at the time of study entry that would preclude completion of the study or the required follow-up.
Facility Information:
Facility Name
Desert Oasis Cancer Center
City
Casa Grande
State/Province
Arizona
ZIP/Postal Code
85222
Country
United States
Facility Name
Arizona Hematology Oncology
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85704
Country
United States
Facility Name
Genesis Cancer Center
City
Hot Springs
State/Province
Arkansas
ZIP/Postal Code
71913
Country
United States
Facility Name
Heritage Physician Group, Oncology
City
Hot Springs
State/Province
Arkansas
ZIP/Postal Code
71913
Country
United States
Facility Name
Pacific Cancer Medical Center, Inc
City
Anaheim
State/Province
California
ZIP/Postal Code
92801
Country
United States
Facility Name
Comprehensive Blood and Cancer Center
City
Bakersfield
State/Province
California
ZIP/Postal Code
93309
Country
United States
Facility Name
Tower Cancer Research Foundation
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90211
Country
United States
Facility Name
Providence St. Joseph Medical Center
City
Burbank
State/Province
California
ZIP/Postal Code
91505
Country
United States
Facility Name
Hematology/Oncology Group of Fresno, Inc
City
Fresno
State/Province
California
ZIP/Postal Code
93720
Country
United States
Facility Name
Comprehensive Cancer Center-Research Office
City
Glendale
State/Province
California
ZIP/Postal Code
91204
Country
United States
Facility Name
Loma Linda University Cancer Institute
City
Loma Linda
State/Province
California
ZIP/Postal Code
92354
Country
United States
Facility Name
Pacific Shores Medical Group
City
Long Beach
State/Province
California
ZIP/Postal Code
90813
Country
United States
Facility Name
Medical Oncology Care Associates
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States
Facility Name
The Cancer Research and Prevention Center
City
Soquel
State/Province
California
ZIP/Postal Code
95073
Country
United States
Facility Name
Bethesda Research Center
City
Boynton Beach
State/Province
Florida
ZIP/Postal Code
33435
Country
United States
Facility Name
Broward Oncology Associates
City
Fort Lauderdale
State/Province
Florida
ZIP/Postal Code
33308
Country
United States
Facility Name
Florida Wellcare
City
Inverness
State/Province
Florida
ZIP/Postal Code
34452
Country
United States
Facility Name
Cancer & Blood Disease Center
City
Lecanto
State/Province
Florida
ZIP/Postal Code
34461
Country
United States
Facility Name
Oncology-Hematology Associates of West Broward
City
Tamarac
State/Province
Florida
ZIP/Postal Code
33321
Country
United States
Facility Name
Hematology Oncology Speaclist
City
Tampa
State/Province
Florida
ZIP/Postal Code
33607
Country
United States
Facility Name
Joliet Oncology Hematology Associates, Ltd.
City
Joliet
State/Province
Illinois
ZIP/Postal Code
60435
Country
United States
Facility Name
Loyola University Health Systems
City
Maywood
State/Province
Illinois
ZIP/Postal Code
60153
Country
United States
Facility Name
Mid-Illinois HEM & ONC Assoc.
City
Normal
State/Province
Illinois
ZIP/Postal Code
61761
Country
United States
Facility Name
Northern Indiana Cancer Research Consortium
City
South Bend
State/Province
Indiana
ZIP/Postal Code
46601
Country
United States
Facility Name
Associated Physicians & Surgeons Clinic
City
Terre Haute
State/Province
Indiana
ZIP/Postal Code
47804
Country
United States
Facility Name
Kentucky Cancer Clinic
City
Hazard
State/Province
Kentucky
ZIP/Postal Code
41701
Country
United States
Facility Name
West Kentucky Hematology & Oncology Group, PSC
City
Paducah
State/Province
Kentucky
ZIP/Postal Code
42003
Country
United States
Facility Name
Cabrini Center for Cancer Care
City
Alexandria
State/Province
Louisiana
ZIP/Postal Code
71301
Country
United States
Facility Name
West Michigan Cancer Center
City
Kalamazoo
State/Province
Michigan
ZIP/Postal Code
49007
Country
United States
Facility Name
Oncology Care Associates, PLLC
City
Saint Joseph
State/Province
Michigan
ZIP/Postal Code
49085
Country
United States
City
Troy
State/Province
Michigan
ZIP/Postal Code
48085
Country
United States
Facility Name
Hubert H. Humphrey Cancer Center
City
Robbinsdale
State/Province
Minnesota
ZIP/Postal Code
55422
Country
United States
Facility Name
St. Louis Cancer Care Center
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Facility Name
Columbia Comprehensive Cancer Care Clinics
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65201
Country
United States
Facility Name
Bond Clinic
City
Rolla
State/Province
Missouri
ZIP/Postal Code
65401
Country
United States
Facility Name
Saint Louis University
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
Washington University Siteman Cancer Center Pharmacy
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States
Facility Name
Montana Cancer Specialists
City
Missoula
State/Province
Montana
ZIP/Postal Code
59802
Country
United States
Facility Name
Sierra Nevada Oncology Care
City
Carson City
State/Province
Nevada
ZIP/Postal Code
89100
Country
United States
Facility Name
Essex Oncology of North Jersey, PA
City
Belleville
State/Province
New Jersey
ZIP/Postal Code
07109
Country
United States
Facility Name
Atlanta HEM ONC
City
Manasquan
State/Province
New Jersey
ZIP/Postal Code
08736
Country
United States
Facility Name
Oncology and Hematology Specialist, PA
City
Mountain Lakes
State/Province
New Jersey
ZIP/Postal Code
07046
Country
United States
Facility Name
San Juan Oncology Association
City
Farmington
State/Province
New Mexico
ZIP/Postal Code
87401
Country
United States
Facility Name
Our Lady of Mercy Medical Center
City
Bronx
State/Province
New York
ZIP/Postal Code
10466
Country
United States
Facility Name
Suny Downstate Medical Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11203
Country
United States
Facility Name
Cancer Treatment Services
City
Corning
State/Province
New York
ZIP/Postal Code
14830
Country
United States
Facility Name
Interlakes Foundation, Inc.
City
Rochester
State/Province
New York
ZIP/Postal Code
14623
Country
United States
Facility Name
Guthrie Clinic
City
Sayre
State/Province
New York
ZIP/Postal Code
18840
Country
United States
Facility Name
New York Medical Collegw
City
Valhalla
State/Province
New York
ZIP/Postal Code
10595
Country
United States
Facility Name
Alamance Cancer Center
City
Burlington
State/Province
North Carolina
ZIP/Postal Code
27215
Country
United States
Facility Name
UNC Chapel Hill Oncology Protocol Office
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Name
Leo Jenkins Cancer Center
City
Greenville
State/Province
North Carolina
ZIP/Postal Code
28734
Country
United States
Facility Name
Northwestern Carolina Oncology & Hematology
City
Hickory
State/Province
North Carolina
ZIP/Postal Code
28602
Country
United States
Facility Name
St. Alexius Medical Center
City
Bismarck
State/Province
North Dakota
ZIP/Postal Code
58501
Country
United States
Facility Name
University of Cleveland
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106
Country
United States
Facility Name
Metro Health Medical Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44109
Country
United States
Facility Name
The Cleveland Clinic Foundation, Taussig Cancer Center
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44195
Country
United States
Facility Name
Dayton Clinical Oncology Program
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45429
Country
United States
Facility Name
Signal Point Hematology/Oncology, Inc.
City
Middletown
State/Province
Ohio
ZIP/Postal Code
45042
Country
United States
Facility Name
Charleston Hematology Oncology
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29403
Country
United States
Facility Name
The Family Cancer Center
City
Collierville
State/Province
Tennessee
ZIP/Postal Code
38077
Country
United States
Facility Name
Mary Crowley Medical Research Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75201
Country
United States
Facility Name
JPS Center for Cancer Care
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Facility Name
Columbia Basin HEM/ONC
City
Kennewick
State/Province
Washington
ZIP/Postal Code
99336
Country
United States
Facility Name
Sanatorio Parque
City
Rosario
State/Province
Santa Fe
ZIP/Postal Code
S2000DSV
Country
Argentina
Facility Name
CETEN
City
Beunos Aires
ZIP/Postal Code
B1874ACL
Country
Argentina
Facility Name
Hospital Privado de Comunidad
City
Buenos Aires
ZIP/Postal Code
B7602CBM
Country
Argentina
Facility Name
Hospital General de Agudos "Dr Teodoro Alvarez"
City
Buenos Aires
ZIP/Postal Code
C1406FWY
Country
Argentina
Facility Name
Instituto Alexander Fleming
City
Ciudad de Buenos Aires
ZIP/Postal Code
C1426ANZ
Country
Argentina
Facility Name
Instituto Oncologico de Cordoba - IONC
City
Cordoba
ZIP/Postal Code
X5000AA1
Country
Argentina
Facility Name
LUCEN
City
Cuidad Autonoma de Buenos Aires
ZIP/Postal Code
C1405CUB
Country
Argentina
Facility Name
ISIS Clinica Especializada
City
Urquiza
ZIP/Postal Code
3022
Country
Argentina
Facility Name
District Oncology Dispensary
City
Plovdiv
ZIP/Postal Code
4000
Country
Bulgaria
Facility Name
District Oncolodispensary with Impatient sector
City
Rousse
ZIP/Postal Code
7002
Country
Bulgaria
Facility Name
Military Medical Academy
City
Sofia
ZIP/Postal Code
1606
Country
Bulgaria
Facility Name
Regional Oncology Dispensary with Inpatient Secot-Sofia District
City
Sogia
ZIP/Postal Code
1233
Country
Bulgaria
Facility Name
Regional Oncology Dispensary with Inpatient Sector
City
Varna
ZIP/Postal Code
9010
Country
Bulgaria
Facility Name
University Mulitprofile Hospital for Active Treatment "Sveta Marina"
City
Varna
ZIP/Postal Code
9010
Country
Bulgaria
Facility Name
University Multiprofile Hospital for Active Treatment "Sveta Marina"
City
Varna
ZIP/Postal Code
9010
Country
Bulgaria
Facility Name
Regional Oncology Dispensary with Inpatient sector
City
Veliko Tarnovo
ZIP/Postal Code
5000
Country
Bulgaria
Facility Name
Jewish General Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3T 1E2
Country
Canada
Facility Name
Erzsebet Juhasz
City
Budapest
ZIP/Postal Code
1529
Country
Hungary
Facility Name
University of Debrecen, Pulmonology Clinic
City
Debreen
ZIP/Postal Code
4032
Country
Hungary
Facility Name
Hospital for Thoracic Diseases of Csongrad Country
City
Deszk
ZIP/Postal Code
6772
Country
Hungary
Facility Name
Pulmonology Institute of Veszprem County
City
Farkasgyepu
ZIP/Postal Code
8582
Country
Hungary
Facility Name
Hospital for Pulmonological Diseases of the Bekes County
City
Gyula
ZIP/Postal Code
5703
Country
Hungary
Facility Name
Hospital of the Chest Desease of the Hungarian Reformed Church
City
Mosdos
ZIP/Postal Code
7257
Country
Hungary
Facility Name
Karolina Hospital
City
Mosonmagyarovar
ZIP/Postal Code
9200
Country
Hungary
Facility Name
Barany County Hospital
City
Pecs
ZIP/Postal Code
7623
Country
Hungary
Facility Name
Erzsebet Hospital
City
Sopron
ZIP/Postal Code
9400
Country
Hungary
Facility Name
Sanatorium for Pulmonological Diseases
City
Torokbalint
ZIP/Postal Code
2045
Country
Hungary
Facility Name
Centenario Hospital Miguel Hidalgo
City
Aguascalientes
State/Province
Ags.
ZIP/Postal Code
20230
Country
Mexico
Facility Name
CIMA Chihuahua
City
Chihuahua
State/Province
Chih
ZIP/Postal Code
31238
Country
Mexico
Facility Name
Hospital General
City
Durango
State/Province
Dgo.
ZIP/Postal Code
34079
Country
Mexico
Facility Name
Instituto Estatal de Cancerologia "Dr. Arturo Beltran Ortega"
City
Acapulco
State/Province
Gro
ZIP/Postal Code
39570
Country
Mexico
Facility Name
Hospital Dr. Angel Leano
City
Zapopan
State/Province
Jalisco
ZIP/Postal Code
45200
Country
Mexico
Facility Name
Hospital Star Medica Morelina
City
Morelia
State/Province
Michoacan
ZIP/Postal Code
58070
Country
Mexico
Facility Name
Monterrey International Research Center
City
Monterrey
State/Province
N.l.
ZIP/Postal Code
64020
Country
Mexico
Facility Name
Centro Estatal de Canceologia
City
Jalapa
State/Province
Veracruz
ZIP/Postal Code
31238
Country
Mexico
Facility Name
Centro Anticanceroso de la Cruz Roja Mexicana de Merida
City
Merida
State/Province
Yucatan
ZIP/Postal Code
9700
Country
Mexico
Facility Name
Centro Estatal de Cancerologia
City
Chihuahua
ZIP/Postal Code
31000
Country
Mexico
Facility Name
Hospital Central "Dr. Ignacio Morones Prieto"
City
San Luis Potosi
ZIP/Postal Code
78240
Country
Mexico
Facility Name
Hospital General Regional
City
Veracruz
ZIP/Postal Code
91700
Country
Mexico
Facility Name
Kujawsko-Pomorskie Centrum Pulmunologii
City
Bydgoszcz
ZIP/Postal Code
85-326
Country
Poland
Facility Name
Krakowski Szpital Specjelistyczny
City
Kawkow
ZIP/Postal Code
31-202
Country
Poland
Facility Name
Centrum Onkologii Ziemii Lubelskiej
City
Lublin
ZIP/Postal Code
20-090
Country
Poland
Facility Name
Zaklad Opieki Zdrowotnej Ministerstaw Spraw Wewnetrznych i Administraeji
City
Olsztyn
ZIP/Postal Code
10-228
Country
Poland
Facility Name
Mazowleckie Centrum leczenia Chorob Pluc i Gruzlicy
City
Otwock
ZIP/Postal Code
05-400
Country
Poland
Facility Name
Wielkopolskie Centrum Chorob Pluc i Gruzlicy, Samodzielmy Publiczny ZOZ
City
Poznan
ZIP/Postal Code
60-569
Country
Poland
Facility Name
SPSK nr l im. Przemienienia AM w Poznaniu
City
Poznan
ZIP/Postal Code
61-848
Country
Poland
Facility Name
MSc Grezegorz Jedrejezak
City
Wroclaw
ZIP/Postal Code
50-891
Country
Poland
Facility Name
Dolnoslaskie Centrum Chorob Pluc ul. Grabiszynska 105
City
Wroclaw
ZIP/Postal Code
53-439
Country
Poland
Facility Name
Institutul Oncologie - Clinic de Oncologie Medicala
City
Bucharest
ZIP/Postal Code
022328
Country
Romania
Facility Name
Prof. Dr. Al. Trestioreanu Institute of Oncology
City
Bucharest
ZIP/Postal Code
022328
Country
Romania
Facility Name
"Prof. Dr. I. Chiricuta" Institute of Oncology
City
Cluj-Napoca
ZIP/Postal Code
400015
Country
Romania
Facility Name
Emergency Clinical County Hospital
City
Craiova
ZIP/Postal Code
200642
Country
Romania
Facility Name
Oradea Clinical County Hospital
City
Oradea
ZIP/Postal Code
410032
Country
Romania
Facility Name
Clinical County Hospital
City
Sibiu
ZIP/Postal Code
550245
Country
Romania
Facility Name
Timisoara Emergency Clinical Municipal Hospital
City
Timisoara
ZIP/Postal Code
300223
Country
Romania
Facility Name
Chelyabinsk Regional Oncology Center
City
Chelyabinsk
ZIP/Postal Code
454087
Country
Russian Federation
Facility Name
Krasnodar City Oncology Center
City
Krasnodar
ZIP/Postal Code
350040
Country
Russian Federation
Facility Name
Moscow Municpal Oncology Hospital #62
City
Moscow Region
ZIP/Postal Code
143423
Country
Russian Federation
Facility Name
Moscow Oncology Clinical Dispensary #1
City
Moscow
ZIP/Postal Code
109033
Country
Russian Federation
Facility Name
SI Russian Oncological Scientific Center after N.N. Blokhim RAMS
City
Moscow
ZIP/Postal Code
115478
Country
Russian Federation
Facility Name
SI Russian Oncological Scientific Center after N.N. Blokhin RAMS
City
Moscow
ZIP/Postal Code
115478
Country
Russian Federation
Facility Name
Centeral ClinicalHospital of the President o the Russian Federation
City
Moscow
ZIP/Postal Code
121356
Country
Russian Federation
Facility Name
Omsk Regional Oncology Center
City
Omsk
ZIP/Postal Code
644013
Country
Russian Federation
Facility Name
Orenburg Regional Oncology Clinical Center
City
Orenburg
ZIP/Postal Code
460021
Country
Russian Federation
Facility Name
St. Petersburg City Clinical Oncology Center
City
Saint Petersburg
ZIP/Postal Code
198255
Country
Russian Federation
Facility Name
Lenigrad Regional Oncology Center
City
St. Petersburg
ZIP/Postal Code
191104
Country
Russian Federation
Facility Name
Leningrad Regional Clinical Hospital
City
St. Petersburg
ZIP/Postal Code
194291
Country
Russian Federation
Facility Name
St. Petersbrug State Medical Pavlov University
City
St. Petersburg
ZIP/Postal Code
197089
Country
Russian Federation
Facility Name
Donetsk Regional Antineoplastic Center
City
Donetsk
ZIP/Postal Code
83092
Country
Ukraine
Facility Name
Ivano-Frankovsk Regional Oncology Center, Ivano-Frankovsk Medical University
City
Ivano-Frankovsk
ZIP/Postal Code
76018
Country
Ukraine
Facility Name
Instiute of Oncology under AMS of Ukraine
City
Kiev
ZIP/Postal Code
3022
Country
Ukraine
Facility Name
Volyn Regional Oncology Dispensary
City
Lutsk
ZIP/Postal Code
43018
Country
Ukraine
Facility Name
Uzhgorod National University, Regional Clinical Oncology Dispensary
City
Uzhgorod
ZIP/Postal Code
88014
Country
Ukraine
Facility Name
Vinnitsa State Medical University
City
Vynnytsya
ZIP/Postal Code
21029
Country
Ukraine
Facility Name
Zaporizhzhya Regional Oncology Dispensary
City
Zaprizhzhya
ZIP/Postal Code
69040
Country
Ukraine
Facility Name
The Royal Bournemouth Hospital
City
Bournemouth
ZIP/Postal Code
BH77DW
Country
United Kingdom
Facility Name
Oncology Pharmacy
City
London
ZIP/Postal Code
SE19RT
Country
United Kingdom
Facility Name
Wythenshaw Hospital, Pharmacy Department
City
Manchester
ZIP/Postal Code
M23 9LT
Country
United Kingdom
Facility Name
Southhampton General Hospital
City
Southhampton
ZIP/Postal Code
SO16 6YD
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

We'll reach out to this number within 24 hrs